REFERENCES
- Aiba T., Yoshinaga M., Ishida K., Takehara Y., Hashimoto Y. Intestinal expression and metabolic activity of the CYP3A subfamily in female rats. Biol. Pharm. Bull. 2005; 28: 311–315
- Bain L. J., LeBlanc G. A. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol. Appl. Pharmacol. 1996; 141: 288–298
- Balayssac D., Authier N., Cayre A., Coudore F. Does inhibition of P-glycoprotein lead to drug-drug interactions?. Toxicol. Lett. 2005; 156: 319–329
- Braunschweig J., Staubli M., Studer H. Interactions of amiodarone with digoxin in rats. Br. J. Pharmacol. 1987; 92: 553–559
- De Lannoy I A., Koren G., Klein J., Charuk J., Silverman M. Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. Am. J. Physiol. 1992; 263: 613–622
- De Lannoy I A., Silverman M. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem. Biophys. Res. Commun. 1992; 189: 551–557
- Ding R., Tayrouz Y., Riedel K. D., Burhenne J., Weiss J., Mikus G., Haefeli W. E. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers. Clin. Pharmacol. Ther. 2004; 76: 73–84
- Fromm M. F., Kim R. B., Stein C. M., Wilkinson G. R., Roden D. M. Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 1999; 99: 552–557
- Funakoshi S., Murakami T., Yumoto R., Kiribayashi Y., Takano M. Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and beta-methyldigoxin in rats. J. Pharm. Sci. 2003; 92: 1455–1463
- Gelal A., Gumustekin M., Kalkan S., Guven H., Eminoglu O. Effects of subchronic parathion exposure on cyclosporine pharmacokinetics in rats. J. Toxicol. Environ. Health. Part A 2001; 62: 289–294
- Lanning C. L., Fine R. L., Sachs C. W., Rao U. S., Corcoran J. J., Abou-Donia M. B. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein. J. Toxicol. Environ. Health 1996; 47: 395–407
- Lecoeur S., Videmann B., Mazallon M. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Toxicol. Lett. 2006; 161: 200–209
- Matheny C. J., Lamb M. W., Brouwer K. R., Pollack G. M. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy 2001; 21: 778–796
- Mayer U., Wagenaar E., Beijnen J. H., Smit J. W., Meijer D. K., van Asperen J., Borst P., Schinkel A. H. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br. J. Pharmacol. 1996; 119: 1038–1044
- Okamura N., Hirai M., Tanigawara Y., Tanaka K., Yasuhara M., Ueda K., Komano T., Hori R. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney. J. Pharmacol. Exp. Ther. 1993; 266: 1614–1619
- Salphati L., Benet L. Z. Effects of ketoconazole on digoxin absorption and disposition in rat. Pharmacology. 1998; 56: 308–313
- Salphati L., Benet L.Z. Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. Xenobiotica. 1999; 29: 171–185
- Song S., Suzuki H., Kawai R., Sugiyama Y. Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. Drug. Metab. Dispos. 1999; 27: 689–694
- Su S. F., Huang J. D. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug. Metab. Dispos. 1996; 24: 142–147
- Sun J., Hei Z. G., Cheng G., Wang S. J., Hao X. H., Zou M. J. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med. Sci. Monit. 2004; 10: RA5–RA14
- Tuncok Y., Guven H., Gelal A., Apaydin S., Gidener S., Fowler J. Poisonings reported to the DPIC in Izmir, Turkey. Toxicol. Lett. 1995; 78: 80
- Wang Y. H., Chao P. D., Hsiu S. L., Wen K. C., Hou Y. C. Lethal quercetin-digoxin interaction in pigs. Life. Sci. 2004; 74: 1191–1197